missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human CD40 Ligand/TNFSF5 (aa 108-261) Protein
Click to view available options
Formulation:
Lyophilized from a 0.2 μm filtered solution in NaH2PO4, NaCl and EDTA with BSA as a carrier protein.
Lyophilized from a 0.2 μm filtered solution in NaH2PO4, NaCl and EDTA.
Unit Size:
50µg
Description
Measured in a cell proliferation assay using B cell-enriched peripheral blood mononuclear cells (PBMC) in the presence of IL-4. Spriggs, M.K. et al. (1992) J. Exp. Med. 176:1543. The ED50 for this effect is 1-3.00 μg/mL in the presence of 20 ng/mL of recombinant human IL-4.
Specifications
Specifications
| Accession Number | P29965 |
| For Use With (Application) | Bioactivity |
| Formulation | Lyophilized from a 0.2 μm filtered solution in NaH2PO4, NaCl and EDTA with BSA as a carrier protein. |
| Gene ID (Entrez) | 959 |
| Molecular Weight (g/mol) | M.W. (Observed): 18 kDa, reducing conditions; M.W. (theoretical): 16.9 kDa (monomer) |
| Name | CD40 Ligand/TNFSF5 aa 108-261 |
| Quantity | 50 μg |
| Source | E. coli-derived human CD40 Ligand/TNFSF5 protein Glu108-Leu261, with an N-terminal Met |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 3 months, 2°C to 8°C under sterile conditions after reconstitution. |
| Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction